Seeking Alpha
  • The Scientist
    CYCC recently trading at cash. Wall St saying their drugs are worth $0! Both lead drugs sapacitabine and seliciclib show activity.
    5/21/12
    Reply (1)
    • The Scientist: Sapacitabine in P3 studies headed by chair of leukemia at MD Anderson. Valuation does not make sense.
      5/21/12